| CAREDX INC. DL-,001 |
| USA |
| Gesundheit |
| US14167L1035 / A118WG |
| 1K9 (Frankfurt) / CDNA (NASDAQ) |
| FRA:1K9, ETR:1K9, 1K9:GR, NASDAQ:CDNA |
| - |
| https://www.caredx.com/ |
|
CareDx Inc. is a leading precision medicine company that discovers, develops, and commercializes clinically differentiated diagnostic solutions for transplant patients and caregivers. It specializes in genomics-based testing services, including AlloS..
>Volltext.. |
| 1300.83 Mio. EUR |
| 1160.52 Mio. EUR |
| 361.45 Mio. EUR |
| 6.61 Mio. EUR |
| -7.17 Mio. EUR |
| -0.13 EUR |
| 21.45 Mio. EUR |
| 68.23 Mio. EUR |
| 63.87 Mio. EUR |
| 2.36 |
| 11.58% |
| -111.19% |
| - |
| - |
| - |
| 2 Insider verkauften innerhalb der letzten 30 Tage Aktien im Wert von 1.634.659 Euro. |
| CAREDX |
| 16.07.26 |
|